Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40001009
Localisation
Switzerland
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
18/07/2024
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2040
Overall Net-Zero Target: Novartis AG commits to reach net-zero greenhouse gas emissions across the value chain by 2040. Near-Term Targets: Novartis commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2030 from a 2022 base year. Novartis also commits to reduce absolute scope 3 GHG emissions 42% within the same timeframe. Long-Term Targets: Novartis commits to maintain a minimum of 90% absolute scope 1 and 2 emissions reductions from 2030 through 2040 from a 2022 base year. Novartis also commits to reduce absolute scope 3 GHG emissions 90% by 2040 from a 2022 base year.
Statut
Targets setAnnée cible
2040
Statut
BA1.5 memberDate d'engagement
01/07/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
CH0012005267
LEI
5493007HIVTX6SY6XD66
Source : Science Based Targets initiative | Données publiques